Infantile Malignant Osteopetrosis clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis
Sorry, in progress, not accepting new patients
The primary objective of this Phase 1 study is to evaluate the therapeutic safety and feasibility of the investigational product (IP), RP-L401.
at UCLA
Our lead scientists for Infantile Malignant Osteopetrosis research studies include Donald B Kohn, MD.
Last updated: